Day One Biopharmaceuticals Inc (DAWN) — Capital Reinvestment Ratio

Latest as of September 2024: 1.10x

Day One Biopharmaceuticals Inc (DAWN) has a Capital Reinvestment Ratio of 1.10x as of September 2024, meaning it reinvests 1% of its operating cash flow ($50.75 Million) in capital expenditures ($55.72 Million). Check tangible equity quality of Day One Biopharmaceuticals Inc to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

1.10x

Capex / Operating Cash Flow

Operating Cash Flow

$50.75 Million

USD

Capital Expenditures

$55.72 Million

USD

Data as of

Sep 2024

Most recent filing

Annual Capital Reinvestment Ratio for Day One Biopharmaceuticals Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Day One Biopharmaceuticals Inc from None to None. See cash generation quality of Day One Biopharmaceuticals Inc to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow